BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16209341)

  • 1. [Significance of MDM2 protein in the cell cycle].
    Szemraj J; Rozpończyk E; Bartkowiak J; Greger J; Oszajca K
    Postepy Biochem; 2005; 51(1):44-51. PubMed ID: 16209341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53.
    Klein AM; Biderman L; Tong D; Alaghebandan B; Plumber SA; Mueller HS; van Vlimmeren A; Katz C; Prives C
    Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34716260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2: life without p53.
    Daujat S; Neel H; Piette J
    Trends Genet; 2001 Aug; 17(8):459-64. PubMed ID: 11485818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function.
    Wu H; Leng RP
    Oncotarget; 2015 Aug; 6(25):21479-92. PubMed ID: 26025930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
    Li L; Liao J; Ruland J; Mak TW; Cohen SN
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and activation of p53 and its family members.
    Lohrum MA; Vousden KH
    Cell Death Differ; 1999 Dec; 6(12):1162-8. PubMed ID: 10637431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
    Gu J; Nie L; Kawai H; Yuan ZM
    Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53.
    Hayashi S; Ozaki T; Yoshida K; Hosoda M; Todo S; Akiyama S; Nakagawara A
    Biochem Biophys Res Commun; 2006 Aug; 347(1):60-6. PubMed ID: 16815295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.
    Hossain S; Iwasa H; Sarkar A; Maruyama J; Arimoto-Matsuzaki K; Hata Y
    Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29891515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.
    Gu J; Chen D; Rosenblum J; Rubin RM; Yuan ZM
    Mol Cell Biol; 2000 Feb; 20(4):1243-53. PubMed ID: 10648610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of p73 and p53 regulation and effector functions.
    Fang L; Lee SW; Aaronson SA
    J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role of p73 on the modulation of p53 level through MDM2.
    Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
    Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 and MDMX bind and stabilize the p53-related protein p73.
    Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
    Ries S; Biederer C; Woods D; Shifman O; Shirasawa S; Sasazuki T; McMahon M; Oren M; McCormick F
    Cell; 2000 Oct; 103(2):321-30. PubMed ID: 11057904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.